Medical News

RSS

'Had Sex': Different perceptions

When people say they "had sex," what transpired is anyone's guess. A new study from the Kinsey Institute at Indiana University found that no uniform consensus existed when a representative sample of 18- to 96-year-olds was asked what the term meant to them.

5 Mar 2010

Liver transplantation specialists form guidelines for allocation of organs for patients with HCC

Liver transplantation specialists recently convened to address U.S. guidelines for allocation of organs for patients with hepatocellular carcinoma (HCC, liver cancer). Representatives from more than 130 U.S. transplant centers were invited to the conference and participants included 180 leaders in liver transplantation (LT) from the 50 most active centers.

5 Mar 2010

NanoViricides files Universal Form S-3 Shelf Registration with SEC

NanoViricides, Inc., reports that it has filed a “Universal Form S-3 Shelf Registration” with the Securities and Exchange Commission for the sale from time to time of up to $40 million of its securities. The Company recently became eligible to file a shelf registration to register its securities.

5 Mar 2010

Johnson & Johnson Consumer to introduce CYTOMIMIC Technology at 68th AAD meeting

Building on decades of research into how the body's electrical field affects skin regeneration, scientists at Johnson & Johnson Consumer Companies, Inc., have discovered how to harness the power of bioelectricity to help improve skin rejuvenation. The new innovation, called CYTOMIMIC™ Technology, is a proprietary, patented technology that combines essential minerals to deliver biological levels of electric signals similar to the skin's natural bioelectricity.

5 Mar 2010

LEO Pharma gains access to Intomics’ biological data analysis expertises

Today, Intomics A/S and LEO Pharma A/S announced a collaboration under which LEO Pharma gains access to Intomics’ unique biological data analysis expertises. The recently founded spin-off company from The Danish Technical University, Intomics, has methods and tools for use in LEO Pharma’s early drug discovery.

5 Mar 2010

Opexa Therapeutics reports net loss of $1,433,922 for year ended December 31, 2009

Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2009 and provided an update on its progress.

5 Mar 2010

FDA's PADAC meeting to review pirfenidone NDA: InterMune posts briefing documents

InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is Esbriet®.

5 Mar 2010

Data to advance the diagnosis, treatment and management of MH to be presented

Travel Award Available to share data with Clinicians and Scientists to advance the diagnosis, treatment, and management of Malignant Hyperthermia-Susceptible Patients April 23-24, 2010 at Mercy Hospital University of Pittsburgh Medical Center.

5 Mar 2010

Promises Treatment Center CEO's insights on Redmond O'Neal's addiction and rehabilitation problems

The unfortunate story of Redmond O'Neal continues to make headlines. He has been an admitted addict since he was a teen and has had multiple drug arrests. He recently appeared in court for a status hearing on his latest stint in rehab.

5 Mar 2010

Grinding teeth at night common among those trying to cope with stress by escaping from difficult situations

People who are stressed by daily problems or trouble at work seem to be more likely to grind their teeth at night. Researchers writing in BioMed Central's open access journal Head & Face Medicine studied the causes of 'sleep bruxism', gnashing teeth during the night, finding that it was especially common in those who try to cope with stress by escaping from difficult situations.

5 Mar 2010

Researchers discuss the synergy between nanoscience and neuroscience

Is it possible to build supercomputers that can replicate the human brain, or to develop nanotechnology that can lead to an implantable chip for interfacing with neurons and other types of cellular networks?

5 Mar 2010

Liberal government's radical health care restructuring plan will deny patients access to local care

Ontarians should be alarmed that the Liberal government is planning a radical restructuring of health care "premised not on quality of care and best practices, but solely on which hospital can do their surgeries most cheaply," says Michael Hurley, the president of the Ontario Council of Hospital Unions (OCHU) - which represents 30,000 CUPE hospital workers.

5 Mar 2010

HOYA ConBio to introduce DermaSculpt and MedLite C5 lasers at AAD Annual Meeting

HOYA ConBio, a global leader in aesthetic medical lasers, will introduce the DermaSculpt Er:YAG and the MedLite C5 Q-Switched Nd:YAG lasers at the 68th Annual Meeting of the American Academy of Dermatology, March 5-9th at the Miami Convention Center (Booth #819).

5 Mar 2010

Stryker Orthopaedics introduces ADM X3 Mobile Bearing Acetabular System for hip replacement surgery

Stryker Orthopaedics today announced the release of the ADM X3 Mobile Bearing Acetabular System, a next-generation technology for hip replacement surgery designed to minimize the risks associated with total hip replacement surgery.

From Stryker 5 Mar 2010

LEO Pharma presents Phase III study results of PEP005 Gel 0.05% for treatment of AK at 68th AAD meeting

Specialty pharmaceutical company LEO Pharma today announced that findings from a Phase III study evaluating PEP005 (ingenol mebutate) Gel 0.05% to treat actinic keratosis (AK), a common pre-cursor to skin cancer, were presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) (Scientific Session Poster Discussion: P105). Results from REGION-I demonstrated treatment with PEP005 Gel once daily for 2 consecutive days.

5 Mar 2010

DUSA Pharmaceuticals to unveil BLU-U Blue Light Photodynamic Therapy Illuminator at AAD meeting

DUSA Pharmaceuticals, Inc.®, a specialty pharmaceutical company focused on dermatology, will unveil an ergonomically enhanced BLU-U® Blue Light Photodynamic Therapy Illuminator at this year's American Academy of Dermatology meeting in Miami, Florida, March 5-9. BLU-U, in conjunction with the Levulan® Kerastick® topical treatment, is an integral part of the Levulan® Photodynamic Therapy (PDT) technology platform.

5 Mar 2010

Phase 1 clinical study of ISIS-SOD1Rx in patients with Lou Gehrig's disease commenced

Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study of ISIS-SOD1Rx in patients with an inherited, aggressive form of Lou Gehrig's disease also known as familial amyotrophic lateral sclerosis (ALS).

5 Mar 2010

Bristol-Myers Squibb to review key accomplishments at meeting with investment community

During a meeting with the investment community today, Bristol-Myers Squibb Company will provide a comprehensive business overview, highlight positive pipeline developments and provide 2013 minimum non-GAAP earnings per share guidance.

5 Mar 2010

eMix announces additional list of medical facilities that are taking part in beta trials

eMix, a new business venture incubated by DR Systems, today announced an additional list of medical facilities that are taking part in beta trials of eMix, the cloud-based technology for sharing imaging studies and reports. Earlier, eMix had announced a partial list of participating facilities.

5 Mar 2010

Insurance and risk management challenges in overseas clinical trials for U.S.-based life sciences companies

The ACE Group of insurance and reinsurance companies today announced the availability of an informational white paper focusing on insurance and risk management issues faced by life sciences companies as they conduct business in the U.S. and globally. The paper, “Managing the Complex Challenges of a Global Insurance Program: Foreign Clinical Trials Case Study,” appeared in the November issue of John Liner Review, and is part of ACE Progress ReportsSM, a collection of white papers, articles and executive reports on current and emerging risk management issues.

5 Mar 2010

Medical News

'Had Sex': Different perceptions

Liver transplantation specialists form guidelines for allocation of organs for patients with HCC

NanoViricides files Universal Form S-3 Shelf Registration with SEC

Johnson & Johnson Consumer to introduce CYTOMIMIC Technology at 68th AAD meeting

LEO Pharma gains access to Intomics’ biological data analysis expertises

Opexa Therapeutics reports net loss of $1,433,922 for year ended December 31, 2009

FDA's PADAC meeting to review pirfenidone NDA: InterMune posts briefing documents

Data to advance the diagnosis, treatment and management of MH to be presented

Promises Treatment Center CEO's insights on Redmond O'Neal's addiction and rehabilitation problems

Grinding teeth at night common among those trying to cope with stress by escaping from difficult situations

Researchers discuss the synergy between nanoscience and neuroscience

Liberal government's radical health care restructuring plan will deny patients access to local care

HOYA ConBio to introduce DermaSculpt and MedLite C5 lasers at AAD Annual Meeting

Stryker Orthopaedics introduces ADM X3 Mobile Bearing Acetabular System for hip replacement surgery

LEO Pharma presents Phase III study results of PEP005 Gel 0.05% for treatment of AK at 68th AAD meeting

DUSA Pharmaceuticals to unveil BLU-U Blue Light Photodynamic Therapy Illuminator at AAD meeting

Phase 1 clinical study of ISIS-SOD1Rx in patients with Lou Gehrig's disease commenced

Bristol-Myers Squibb to review key accomplishments at meeting with investment community

eMix announces additional list of medical facilities that are taking part in beta trials

Insurance and risk management challenges in overseas clinical trials for U.S.-based life sciences companies

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News